Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.15% Nasdaq Up0.28%

Dr. Reddy's Laboratories Ltd. (RDY)

-NYSE
43.33 Up 0.22(0.51%) 2:10PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
ProfileGet Profile for:
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337
Road No 3
Hyderabad, 500034
India - Map
Phone: 91 40 4900 2900
Fax: 91 40 4900 2999
Website: http://www.drreddys.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Full Time Employees:16,617

Business Summary 

Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company. It operates in three segments: Pharmaceutical services and Active Ingredients (PSAI), Global Generics, and Proprietary Products. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in the operation of biologics business. The Proprietary Products segment engages in the discovery and development of new chemical entities for subsequent commercialization and out-licensing. It offers new, synergistic combination, and technology formulations that modifies pharmacokinetics of existing medicines. This segment is also involved in the Company’s specialty pharmaceuticals business that includes sales and marketing operations for in-licensed and co-developed dermatology. The company offers its products and services primarily in the areas of gastrointestinal, cardiovascular, pain management, and oncology therapies. It primarily operates in India, the United States, Russia and other countries of the former Soviet Union, Europe, and others. The company has strategic partnership with Galena Biopharma for the development and commercialization of NeuVax, a immunodominant nonapeptide derived from the extracellular domain of the HER2 protein. Dr. Reddy’s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Dr. Reddy's Laboratories Ltd.

Key Executives 
 PayExercised
Mr. Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.), 54
Chairman, Chief Exec. Officer, Member of The Management Council, Member of Management Committee, Member of Shareholders' Grievance Committee, Member of Investment Committee and Member of Corp. Social Responsibility Committee
1.52MN/A
Mr. Kallam Satish Reddy B.Tech., M.S., 47
Managing Director, Vice-Chairman, Member of The Management Council, Exec. Director, Member of Management Committee, Member of Shareholders' Grievance Committee, Member of Investment Committee and Member of Corp. Social Responsibility Committee
1.50MN/A
Mr. Saumen Chakraborty B.Sc. (H), MBA-IIM, 53
Chief Financial Officer, Global Head of Information Technology & Bus. Process Excellence and Member of The Management Council
N/AN/A
Mr. Abhijit Mukherjee B.Tech. (Chem.), 56
Pres of Global Generics and Member of The Management Council
N/AN/A
Mr. Umang Vohra B.E., M.B.A., 43
Head of North America Generics Bus., Exec. VP and Member of Management Council
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.